Font Size:
a
A
A
Keyword [anticancer agents]
Result: 21 - 40 | Page: 2 of 3
21.
SAR Study Of Bis(3-indolyl)Methane(DIM)Compounds As Anticancer Agents Targeting Orphan Nuclear Receptor Nur77
22.
DNA damage and cell cycle checkpoint regulation: The search for novel anticancer agents and combinations
23.
Preclinical pharmacology of novel synthetic iminoquinones as anticancer agents
24.
Schweinfurthins as novel anticancer agents
25.
Design, synthesis, biological evaluation and molecular modeling of novel taxane-based anticancer agents and paclitaxel mimics
26.
Overcoming multi-drug resistance using GST-activated anticancer agents
27.
Preclinical exploration of novel small molecules as anticancer agents in triple-negative and HER2/neu-positive breast cancers
28.
Total synthesis of dictyostatin analogs for anticancer agents
29.
The role of NQO1 in the metabolism of benzoquinone ansamycin Hsp90 inhibitors and development of novel Hsp90 inhibitors as anticancer agents
30.
Design, synthesis and biological evaluation of novel tumor-targeting taxane-based anticancer agents
31.
Development of farnesyltransferase and geranylgeranyltransferase-I inhibitors as potential antimalarial and anticancer agents
32.
The design, synthesis and biological evaluation of novel taxoid anticancer agents and their tumor-targeted drug conjugates
33.
Design, synthesis and biological evaluation of novel taxane-based anticancer agents and their tumor targeting delivery
34.
Synthesis of anticancer agents for inhibition of type II inosine monophosphate dehydrogenase (IMPDH)
35.
Small molecule-based drug design of anticancer agents that target protein kinase B/AKT, Bcl-xL and DNA methyltransferases for the treatment of prostate cancer
36.
A role forp53 in sensing DNA damage and triggering apoptotic responses to anticancer agents
37.
Preclinical pharmacokinetic and pharmacodynamic evaluation of new anticancer agents for brain tumor chemotherapy
38.
Investigating Molecular Targets of Phosphaplatins: A Class of Novel Non-DNA-Binding Platinum Anticancer Agents in the Treatment of Ovarian Cancer
39.
Clinical pharmacokinetics and pharmacodynamics of anticancer agents delivered via PEGylated liposomes
40.
In search of selective and potent Golgi alpha-mannosidase II inhibitors as potential anticancer agents: Synthesis of 3-substituted-swainsonine analogs and preparation of immobilized swainsonine analogs on solid support
<<First
<Prev
Next>
Last>>
Jump to
